CEO: | Stephen O'Hara |
Finance Director: | David Blain |
Non-Executive Chairman: | Neil Davidson |
Research and Development Director: | Sofia Kolyda |
Non-Executive Dir: | Sean Christie |
Address: | 145-147 St John Street, London, EC1V 4PY |
Phone: | + 44 (0) 203 178 5618 |
Website: | http://www.optibiotix.com |
Sector: | Pharma and Biotech(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | GB00BP0RTP38 |
Currency | UK Pounds |
Share Price | 12.75p |
Change Today | -0.25p |
% Change | -1.92 % |
52 Week High | 33.00 |
52 Week Low | 10.25 |
Volume | 131,326 |
Shares Issued | 103.30m |
Market Cap | £13.17m |
Beta | 0.02 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
16:25 | 3,130 @ 12.93p |
16:21 | 13,754 @ 12.56p |
16:19 | 40,000 @ 12.75p |
16:13 | 2,951 @ 13.01p |
14:26 | 3,775 @ 13.10p |
CEO | Stephen O'Hara |
Finance Director | David Blain |
You are here: research